New Market Study, "Benign Prostatic Hyperplasia - Pipeline Review, H1 2013", Has Been Published
Global Markets Direct's, 'Benign Prostatic Hyperplasia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Benign Prostatic Hyperplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Benign Prostatic Hyperplasia. Benign Prostatic Hyperplasia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release